Clinical Trial Update: Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of NNC0194 0499 and semaglutide for non-alcoholic steatohepatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• NNC0194-0499
• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED